CareDx, Inc

NASDAQ:CDNA

Medical - Diagnostics & Research

Healthcare
$74.44 +5.07%

+$1.19 today

Market cap
$3.91B
Beta
2.48
P/E (TTM)
-154.0
EPS (TTM)
-$0.16
52W Low $10.96High $24.96

Volume 0.54M

Average 0.74M

CDNA Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

CareDx, IncNASDAQ: CDNA

Accounts Payables · Q2 FY2026 · quarter ended Jun 2026

Accounts payables declines year over year

Q2 FY2026 accounts payables of $1.2M fell 4.1% year over year, ahead of the -98.8% change in trailing-twelve-month accounts payables.

Context

  • Accounts payables amounted to 0.2% of revenue in FY2025, down 1.3 pp from a year earlier.
  • Accounts payables increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -4.1% holds above the trailing-twelve-month pace of -98.8%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$1.2M+454.1% QoQ
Last fiscal yearDec 2025
$808K+115.8% YoY
LTMJun 2026
$42K-98.8% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-4.1%——
1 year+115.8%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
808K USD
Year-over-year change
+115.8%
4-year CAGR
-18.0%

Accounts Payables vs competitors

How CDNA compares with its peers on the latest reported figures

  • CDNA's LTM Jun 2026 accounts payables of $42K is the smallest of the 8 companies compared; the peer median is $800K.
  • Its year-over-year change of -98.8% is the 4th highest of 7, against a peer median of -100.2%.
  • Accounts payables amounts to 0.0% of revenue for CDNA, versus a peer median of 0.5%.
CDNA Competitors Peer median
Accounts Payables for CDNA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
NTRANatera, Inc.LTM Jun 2026$29.39M +734.8%-48.3%1.1%
WGSGeneDx Holdings Corp.LTM Jun 2026$5.65M -882.7%-29.5%1.2%
MYGNMyriad Genetics, Inc.LTM Mar 2026$4M +385.7%-26.3%0.5%
BLLNBillionToOne, Inc.LTM Jun 2026$3.33M ——0.8%
QGENQiagen N.V.LTM Jun 2026$1.56M -130.5%+68.6%0.1%
FLGTFulgent Genetics, Inc.LTM Mar 2026$800K -69.8%—0.2%
VCYTVeracyte, Inc.LTM Jun 2026$394K -176.7%—0.1%
CDNACareDx, IncLTM Jun 2026$42K -98.8%—0.0%
Peer median (excluding CDNA) $800K-100.2%-27.9%0.5%

Competitors are the stored peer set for CDNA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(30.66M)(76.61M)(190.28M)52.55M(21.35M)
Depreciation & Amortization11.89M16.01M19.82M19.76M20.42M
Deferred Income Tax00566K(187K)17K
Stock-Based Compensation36.08M46.55M49.09M66.41M34.86M
Change in Working Capital(40.97M)(14.22M)106.03M(102.31M)3.81M
Accounts Receivables(24.42M)(6.66M)16.02M(13.74M)22.52M
Inventory(6.93M)(2.86M)54K(1.02M)(4.96M)
Accounts Payables1.79M(2.05M)2.9M(5.11M)808K
Other Working Capital(11.42M)(2.64M)87.06M(82.44M)(14.56M)
Other Non-Cash Items4.37M3.03M(3.61M)1.83M4.28M
Operating Cash Flow(19.29M)(25.24M)(18.39M)38.05M42.03M
Capital Expenditures(20.26M)(24.33M)(9.24M)(6.48M)(5.91M)
Acquisitions (Net)(15.43M)(610K)(6.68M)00
Purchases of Investments(5.5M)(315.15M)(201.17M)(160.29M)(145.93M)
Sales of Investments88.91M111.59M256.04M166.92M154.67M
Other Investing Activities001.5M(634K)0
Investing Cash Flow47.71M(228.5M)40.45M(483K)2.16M
Debt Repayment(66K)0000
Common Stock Issued188.86M0008M
Common Stock Repurchased0(642K)(27.54M)(522K)(87.77M)
Dividends Paid00000
Other Financing Activities(3.15M)(3.89M)(2.07M)(5.08M)(13.62M)
Financing Cash Flow185.64M(4.54M)(29.61M)(5.61M)(93.39M)
Effect of Forex Changes(303K)23K(112K)532K(90K)
Net Change in Cash213.76M(258.25M)(7.66M)32.49M(49.29M)
Free Cash Flow(39.55M)(49.57M)(27.63M)31.56M36.12M

CareDx, Inc

NASDAQ:CDNA

Intrinsic Alpha fair value

Locked

Current Price

$74.44

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.